Multidrug-resistant infections pose a major quandary for clinicians by complicating therapy choice, compromising patient recovery, and creating a serious threat to public health ([1][1]). In Gram-negative bacteria, resistance to almost all β-lactam antibiotics, including the carbapenems, can be
No takes yet. Share an insight, caveat, or question.
Davey et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: